Perrigo | PRGO - Equity Capital And Reserves


Perrigo reported $2.52B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -5.94B 721M Jun/2026
Abbott USD 52.06B 69M Mar/2026
Bayer EUR 29.71B 863M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Coherus Biosciences USD 60.84M 17.78M Jun/2026
Corcept Therapeutics USD 705.78M 67.79M Jun/2026
Dr.Reddys Laboratories INR 386.74B 7.82B Jun/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Merck USD 41.93B 3.94B Jun/2026
Nestle CHF 29.23B 3.58B Jun/2026
Pacira USD 671.98M 18.08M Jun/2026
Perrigo USD 2.52B 17M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Phibro Animal Health USD 385.48M 23.65M Jun/2026
Prestige Brands USD 1.92B 29.2M Jun/2026
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
Sanofi EUR 69.57B 3.24B Jun/2026
Supernus Pharmaceuticals USD 1.03B 45.58M Jun/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026
Xeris Pharmaceuticals USD -9.73M 22.74M Jun/2026
Zoetis USD 3.15B 85M Jun/2026